Medical Oncology Unit, Department of Internal Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Department of Radiology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Urol Int. 2020;104(3-4):269-272. doi: 10.1159/000502664. Epub 2019 Sep 3.
Crizotinib is an anaplastic lymphoma kinase (ALK) inhibitor that was approved for ALK-harboring lung cancer. There have been reports about the development and progression of renal cysts from crizotinib. We report a series of 3 cases of crizotinib-associated renal cysts in patients admitted to our institution, with different kinds of presentation. A monitor for complex renal cysts is warranted in patients receiving crizotinib.
克唑替尼是一种间变性淋巴瘤激酶 (ALK) 抑制剂,已被批准用于治疗含有 ALK 的肺癌。已有报道称,克唑替尼可导致肾囊肿的发生和进展。我们报告了 3 例在我院就诊的克唑替尼相关肾囊肿患者,他们的临床表现各不相同。接受克唑替尼治疗的患者需要对复杂肾囊肿进行监测。